Scroll
A Customer-Centric, Innovative,
and Reliable CDMO with Global Solutions
One-Stop Services & Solution
Small Molecules CDMO Services
As a global CDMO (Contract Development and Manufacturing Organization) provider, Porton offers efficient, flexible, and high-quality solutions for custom development and production of small molecule APIs, as well as technical services throughout the entire lifecycle from pre-clinical to commercial to our worldwide partners.
More
Tides CDMO Services
With four major R&D platforms including peptides, oligonucleotides, high-performance liquid chromatography, and Tides analysis, the Porton Tides CDMO Services Platform is committed to providing integrated CMC solutions for global customers, covering all types of new drugs from pre-clinical to commercial.
More
Biologics and Conjugates CDMO Services
As a subsidiary of Porton Pharma Solutions, a globally recognized CDMO, Porton Biologics and Conjugates CDMO Platform offers comprehensive, one-stop drug development and manufacturing services for biologics and conjugates, including ADCs, AOCs, PDCs, and more.
More
Advanced Therapy Medicinal Products CRO & CDMO Services
We provide end-to-end CRO and CDMO services from cell banking, process development (PD), analytical development (AD), GMP manufacturing, testing to fill & finishing services for plasmid, viral vectors, and mRNA at research, pre-clinical, and commercial stages.
More
Global Network
Global Network
China
-
Chongqing
Headquarters, R&D, GMP
Manufacturing, DS, DP -
Shanghai
Headquarters, R&D, GMP
Manufacturing, DS, DP
Biologics (mAb & ADC)
Yichun
GMP Manufacturing, DS
Xiaogan
Manufacturing, RSM
Denmark
-
Copenhagen, Denmark
Office
Switzerland
-
Root, Switzerland
Office
Belgium
-
Turnhout, Belgium
Office
Starting with small molecule drug manufacturing, Porton has expanded to a versatile range of capabilities supported by strong global professional teams and excellent facilities. Our formulation CDMO and biologics CDMO capabilities are built on the sound foundations of API crystallization, complex formulation, and gene & cell therapy technologies.
Environmental, Social and Corporate Governance
At Porton, we are guided by the ESG principles of “green development, promoting common progress, building a healthy society together, and enhancing corporate governance." These principles drive our sustainable development and our efforts to create greater environmental and social value.
News
2024-09-30
Technology-Driven | Porton’s Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference
2024-09-19
Porton Showcases At CPhI Europe, Meeting Your CDMO Experts In Booth 5C17
2024-09-19
Presenter Profile Reveal, Meeting Your CDMO Experts In Booth 5C17
